,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2018-05-30 03:00:00,"Shares of Veeva (NYSE: VEEV) have rallied about 40% this year, as the healthcare cloud services provider topped first-quarter analyst estimates with robust sales and earnings growth.",0.9553102254867554,0.021770203486084938,0.022919470444321632,positive,0.9335400462150574
1,2018-05-30 03:00:00,"Its revenue rose 22% annually to $195.5 million, beating estimates by $6.6 million.",0.9534881711006165,0.023180758580565453,0.023330988362431526,positive,0.9303073883056641
2,2018-05-30 03:00:00,"Its non- GAAP net earnings grew 43% to $0.33 per share, exceeding expectations by $0.02.",0.9583402276039124,0.023448064923286438,0.018211690708994865,positive,0.9348921775817871
3,2018-05-30 03:00:00,"Veeva also raised its full-year sales guidance from $815 million-$820 million to $826 million-$830 million, implying 21% sales growth at the midpoint.",0.9566680788993835,0.018055755645036697,0.025276167318224907,positive,0.9386123418807983
4,2018-05-30 03:00:00,Analysts had expected just 19% growth.,0.08772497624158859,0.20916657149791718,0.7031084895133972,neutral,-0.12144159525632858
5,2018-05-30 03:00:00,"It also hiked its EPS guidance from $1.30-$1.33 to $1.36-$1.38, which represents 47% growth at the midpoint and surpasses the consensus forecast for 42% growth.",0.9447236061096191,0.028455067425966263,0.02682126685976982,positive,0.916268527507782
6,2018-05-30 03:00:00,"Those are great growth figures, but Veeva's stock isn't cheap.",0.0908198133111,0.3702661991119385,0.5389139652252197,neutral,-0.27944639325141907
7,2018-05-30 03:00:00,"At $77, it trades at 56 times this year's earnings.",0.7906551361083984,0.026068102568387985,0.18327677249908447,positive,0.7645870447158813
8,2018-05-30 03:00:00,"However, I think that Veeva could still be a great long-term growth play for four simple reasons.",0.33689936995506287,0.011345443315804005,0.651755154132843,neutral,0.32555392384529114
9,2018-05-30 03:00:00,Veeva provides cloud-based customer relationship management (CRM) services for healthcare companies.,0.043271590024232864,0.005085988435894251,0.9516423940658569,neutral,0.03818560019135475
10,2018-05-30 03:00:00,"Its core products include the Veeva Vault, which tracks prescribing habits, clinical trials, and industry regulations; and the Veeva Commercial Cloud, which helps drug companies maintain customer relationships.",0.05673174932599068,0.004482058342546225,0.9387861490249634,neutral,0.052249692380428314
11,2018-05-30 03:00:00,"Veeva's services are useful for drug companies and healthcare providers, since they provide an updated database of information that can be used to produce or prescribe drugs.",0.14289623498916626,0.005329342558979988,0.8517743945121765,neutral,0.13756689429283142
12,2018-05-30 03:00:00,"It also recently launched Veeva Nitro, a next-gen commercial data warehouse specifically designed for life science needs.",0.1978927105665207,0.00550804240629077,0.796599268913269,neutral,0.19238467514514923
13,2018-05-30 03:00:00,Nitro leverages artificial intelligence (AI) technologies to help companies efficiently organize and analyze their stored data.,0.33160844445228577,0.007516705431044102,0.6608749032020569,neutral,0.32409173250198364
14,2018-05-30 03:00:00,"Veeva entered the cloud healthcare market over a decade ago, giving it a first-mover advantage, which enabled it to accumulate over 625 customers, including pharmaceutical giants GlaxoSmithKline , Novartis , and AstraZeneca .",0.8656777739524841,0.012460588477551937,0.12186162918806076,positive,0.8532171845436096
15,2018-05-30 03:00:00,Those massive customers won't suddenly move their data to a more diversified platform like salesforce.com 's (NYSE: CRM) Health Cloud.,0.2548075020313263,0.010486043058335781,0.734706461429596,neutral,0.24432146549224854
16,2018-05-30 03:00:00,2.,0.020992202684283257,0.01708322763442993,0.9619246125221252,neutral,0.003908975049853325
17,2018-05-30 03:00:00,"Salesforce is more of a partner than a rival

Salesforce's Health Cloud offers some services similar to Veeva's, but the two platforms aren't direct competitors.",0.06359084695577621,0.030881544575095177,0.905527651309967,neutral,0.03270930051803589
18,2018-05-30 03:00:00,Salesforce focuses more on patient care and personalized medicine instead of clinical trials and pharmaceutical companies.,0.025524141266942024,0.007508681621402502,0.9669672250747681,neutral,0.018015459179878235
19,2018-05-30 03:00:00,"Veeva founder and CEO Peter Gassner was previously senior VP of technology at Salesforce, and Veeva's platform is actually built on Salesforce's CRM platform and integrated into its marketing and service clouds.",0.04218803718686104,0.0052938866429030895,0.952518105506897,neutral,0.03689415007829666
20,2018-05-30 03:00:00,"The bears often claim that Salesforce could develop a Veeva-like service of its own, but that would be an odd move, since the two companies' partnership is mutually beneficial, and Salesforce would likely struggle to convert Veeva's well-established customer base.",0.15549936890602112,0.5910765528678894,0.2534240782260895,negative,-0.4355771839618683
21,2018-05-30 03:00:00,Demand for real-time healthcare industry data should continue rising over the next few years.,0.8986371755599976,0.014143810607492924,0.08721904456615448,positive,0.884493350982666
22,2018-05-30 03:00:00,Research and Markets expects the healthcare cloud computing market to grow from $20.2 billion in 2017 to $35 billion by 2022 at a compound annual growth rate of 11.6%.,0.9312700033187866,0.013203511945903301,0.055526554584503174,positive,0.9180665016174316
23,2018-05-30 03:00:00,"This indicates that Veeva has room to run, and that there's likely enough room in this expanding market for multiple providers to thrive.",0.8748536109924316,0.011867256835103035,0.11327914893627167,positive,0.8629863262176514
24,2018-05-30 03:00:00,"Unlike many high-growth cloud companies, Veeva is consistently profitable by both non-GAAP and GAAP standards.",0.8335651755332947,0.013500715605914593,0.15293414890766144,positive,0.8200644850730896
25,2018-05-30 03:00:00,"Its GAAP net income rose 20% annually to $37 million last quarter, while its non-GAAP net income jumped 50% to $51.4 million.",0.9528801441192627,0.018185511231422424,0.028934288769960403,positive,0.9346946477890015
26,2018-05-30 03:00:00,"Veeva achieves that stable profit growth by keeping close tabs on its operating expenses, which climbed 27% annually last quarter but only accounted for 47% of its total revenue.",0.3197772204875946,0.08552833646535873,0.5946944355964661,neutral,0.23424887657165527
27,2018-05-30 03:00:00,"Its stock-based compensation expenses -- often a sore spot for high-growth tech companies -- used up just 9% of its revenue, compared to 7% a year earlier.",0.0474947914481163,0.9002267122268677,0.052278488874435425,negative,-0.8527319431304932
28,2018-05-30 03:00:00,"Veeva's non-GAAP and GAAP gross margins both hover near 70%, with higher subscription margins mostly offsetting minor declines in professional service margins.",0.20756737887859344,0.7525857090950012,0.03984692692756653,negative,-0.5450183153152466
29,2018-05-30 03:00:00,Veeva maintains those high margins and generates stable profits because it dominates a niche market and has no direct competition.,0.6926709413528442,0.011547790840268135,0.2957812547683716,positive,0.6811231374740601
30,2018-05-30 03:00:00,"By comparison, other cloud service companies often flounder as they engage rivals in price wars and fund expanding sales forces with higher stock bonuses.",0.13616637885570526,0.5061253905296326,0.35770824551582336,negative,-0.3699589967727661
31,2018-05-30 03:00:00,Veeva isn't a stock for queasy investors.,0.022897113114595413,0.0237269327044487,0.9533759355545044,neutral,-0.0008298195898532867
32,2018-05-30 03:00:00,"However, I believe that it's a solid long-term investment in the growing healthcare cloud market.",0.8673477172851562,0.011102785356342793,0.12154949456453323,positive,0.8562449216842651
33,2018-05-30 03:00:00,"It has a wide moat, a growing customer base of industry leaders, and an expanding ecosystem for cross-selling services -- all topped off with rock-solid profit growth.",0.9249868988990784,0.013937697745859623,0.061075348407030106,positive,0.9110491871833801
34,2018-05-30 03:00:00,"10 stocks we like better than Veeva Systems

When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen.",0.12699975073337555,0.025114860385656357,0.8478853702545166,neutral,0.1018848866224289
35,2018-05-30 03:00:00,"After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor , has quadrupled the market.",0.8087436556816101,0.0373060368001461,0.15395022928714752,positive,0.7714376449584961
36,2018-05-30 03:00:00,"*

David and Tom just revealed what they believe are the 10 best stocks for investors to buy right now... and Veeva Systems wasn't one of them!",0.2355690747499466,0.014962825924158096,0.7494681477546692,neutral,0.2206062525510788
37,2018-05-30 03:00:00,That's right -- they think these 10 stocks are even better buys.,0.8146857619285583,0.02307075634598732,0.16224350035190582,positive,0.7916150093078613
38,2018-05-30 03:00:00,Click here to learn about these picks!,0.0694708302617073,0.055800698697566986,0.8747285008430481,neutral,0.01367013156414032
39,2018-05-30 03:00:00,"*Stock Advisor returns as of May 8, 2018

Leo Sun owns shares of GlaxoSmithKline.",0.019830329343676567,0.007346159312874079,0.972823441028595,neutral,0.012484170496463776
40,2018-05-30 03:00:00,The Motley Fool owns shares of and recommends Salesforce.com and Veeva Systems.,0.030059725046157837,0.018141884356737137,0.9517984390258789,neutral,0.0119178406894207
41,2018-05-30 03:00:00,The Motley Fool has a disclosure policy .,0.016547100618481636,0.017303917557001114,0.9661489725112915,neutral,-0.0007568169385194778
42,2018-05-30 03:00:00,"The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.010204566642642021,0.01563790813088417,0.9741575717926025,neutral,-0.005433341488242149
